Pharma Talk

Thursday, 23 February 2012

Global Regulatory Requirements Material (Pharmaceutics Sem 2 )

Validation of Pharmaceutical Processes, Equipments/Apparatus

Basics in drug approval process with ref. to

IND, NDA, ANDA, CONCEPT OF PARA I TO IV, EXCLUSIVITY

U.S. Food and Drug Administration

INTRODUCTION HISTORY STRUCTURE OF MCC STRUCTURE OF MRA

ANVISA

COMMON TECHNICAL DOCUMENT (CTD) & EUROPEAN MEDICINES AGENCY (EMEA)

MHRA

Therapeutic Goods Administration

ICH, WHO AND SUPAC GUIDELINES
Posted by Pharma Talk at 06:46
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Followers

About Me

My photo
Pharma Talk
View my complete profile

Blog Archive

  • ►  2013 (1)
    • ►  June (1)
  • ▼  2012 (7)
    • ►  October (1)
    • ►  August (1)
    • ►  June (1)
    • ►  April (1)
    • ►  March (1)
    • ▼  February (2)
      • NDDS - 1 Material (Pharmaceutics sem 2)
      • Global Regulatory Requirements Material (Pharmaceu...
  • ►  2011 (30)
    • ►  December (1)
    • ►  October (3)
    • ►  September (3)
    • ►  August (4)
    • ►  July (19)
Ethereal theme. Powered by Blogger.